Tenofovir Alafenamide Tablets 25 Mg - TENQUOR 25 Tablets

TENQUOR 25 Tablets – Next-Gen Protection for HIV & HBV.

TENQUOR 25 Tablets – Tenofovir Alafenamide Tablets 25 Mg is a next-generation nucleotide reverse transcriptase inhibitor (NtRTI) used in the management of HIV-1 infection and chronic Hepatitis B virus (HBV) infection. By blocking viral replication, it lowers the viral load, slows disease progression, and preserves immune function. Compared to earlier tenofovir formulations, TAF delivers strong antiviral activity at a much lower dose, significantly minimizing the risks of renal impairment and bone density loss, making it a safer and more effective long-term therapy option.

Key Benefits of Tenofovir Alafenamide – TENQUOR 25 Tablets
✅ Strong Dual Antiviral Effect – Provides effective suppression of both HIV-1 and HBV replication.
✅ Enhanced Safety & Tolerability – Lower systemic exposure than Tenofovir Disoproxil Fumarate (TDF), reducing risks of kidney and bone toxicity.
✅ Simple Once-Daily Regimen – Improves treatment adherence and long-term therapeutic success.

Recommended by Specialists
👨‍⚕️ Hepatologists & Gastroenterologists – For treatment of chronic hepatitis B infection and prevention of HBV complications.
👨‍⚕️ General Physicians – For long-term antiviral and antiretroviral therapy in routine care settings.
👩‍⚕️ HIV Specialists – For adults and adolescents requiring ART regimens for HIV-1.

Indications
✅ Chronic Hepatitis B Infection
✅ HIV-1 Infection Management (as part of combination therapy)
✅ HBV Reactivation Prophylaxis
✅ Safer Antiviral Option in Patients with Renal Concerns
✅ Core Component of Antiretroviral Therapy (ART) Regimens